Carisbamate is primarily used in the treatment of epilepsy, particularly for managing partial-onset seizures. It functions as an anticonvulsant, helping to stabilize electrical activity in the brain and reduce the frequency and severity of seizures. Additionally, it has been explored for its potential neuroprotective properties, which may offer benefits in conditions involving neuronal damage. Its mechanism of action involves modulating sodium channels and enhancing GABAergic activity, contributing to its effectiveness in controlling seizure episodes. Research continues to investigate its broader therapeutic applications in neurological disorders.